{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-091581","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.283531+00:00","generated_at":"2026-05-18T13:21:31.994135+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aptevo raises $15.9M in Q2 equity offerings, believes it regains Nasdaq compliance on stockholders' equity","bullets":["Raised approx. $15.9M via four equity transactions: April 4 ($2.1M), April 22 ($2.0M), June 20 ($8.0M), and ATM facility ($3.8M).","Company believes stockholders' equity now exceeds the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).","Awaiting formal confirmation from Nasdaq of compliance; previously disclosed deficiency for quarter ended March 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-091581","json":"https://secwatch.observer/filing/0000950170-25-091581.json","markdown":"https://secwatch.observer/filing/0000950170-25-091581.md","text":"https://secwatch.observer/filing/0000950170-25-091581.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025091581/0000950170-25-091581-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025091581/apvo-20250630.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T13:21:31.994135+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}